Asian share markets are trading higher today following gains on Wall Street as immediate concerns over the strength of the global financial system dissipated.

The Nikkei is down 1.4% while the Hang Seng is trading higher by 0.3%. The Shanghai Composite is trading higher by 0.2%.

Wall Street indices jumped on Monday after a deal to rescue Credit Suisse and central bank efforts to bolster confidence in the financial system relieved investors.

Investors also weighed the likelihood of a pause in rate hikes from the Federal Reserve this week.

The Dow Jones Industrial Average ended 1.2% higher while the tech-heavy Nasdaq Composite gained 0.3%.

Here's a table showing how US stocks performed on Monday:

Source: Equitymaster

Back home, Indian share markets are trading on a positive note tracking the trend of global markets and SGX Nifty.

At present, the BSE Sensex is trading higher by 283 points. Meanwhile, the NSE Nifty is trading up by 79 points.

Bajaj FinanceHCL Technologies and Titan are among the top gainers today.

Tech Mahindra and Power Grid on the other hand are among the top losers today.

Broader markets are trading on a positive note. The BSE Mid Cap index is up 0.1% and the BSE Small Cap index trading higher by 0.2%.

Sectoral indices are trading on a mixed note. Stocks in the consumer durables sector and telecom sector witness buying.

Meanwhile, stocks in the IT sector and the oil and gas sector witness selling.

Shares of KPIT Technologies and Siemens hit their 52-week high today.

The rupee is trading at Rs 82.63 against the US dollar.

In the commodity markets, gold prices are trading higher by Rs 109 at Rs 59,619 per 10 grams.

Meanwhile, silver prices are trading higher by 0.1% at Rs 68,892 per 1 kg.

Now track the biggest movers of the stock market using the stocks to watch today section. This should help you keep updated with the latest developments...
 

M&M completes acquisition of MITRA Agro Equipments

Mahindra & Mahindra (M&M) on Monday, 20 March 2023, said the company's farm equipment sector (FES) completed the acquisition of MITRA Agro Equipments Private for Rs 617.1 million (m).

The company will increase its shareholding from the existing 47.3% to 100% in MITRA Agro Equipments.

This will make MITRA a wholly-owned subsidiary of M&M with effect from 17 March 2023. As part of this acquisition, Mahindra fully bought out omnivore's stake in the business.

Founded in 2012 by Devneet Bajaj, MITRA is the Indian market leader in high-precision orchard sprayers and a trusted brand for farmers growing fruits like grapes, pomegranates, and oranges.

Post-acquisition by Mahindra, MITRA plans to accelerate the expansion of its product portfolio alongside its network in India and overseas markets.

MITRA was an early entrant in the then-nascent Indian agritech startup ecosystem. Omnivore, a venture capital firm that pioneered agritech investing in India, was one of its first institutional investors.

This news might finally bring relief for investors because as of late M&M's share price was falling.

Warburg Pincus sells a 2.5% stake in PVR Cinemas

Private equity company Warburg Pincus divested a 2.5% stake in multiplex-chain company PVR for Rs 3.8 billion (bn) through open market transactions.

Warburg Pincus, through its affiliate Berry Creek Investment, sold the shares in PVR.

According to the block deal data available with the BSE, Berry Creek Investment sold a total of 2,439,301 shares in three tranches, amounting to a 2.5% stake in the firm.

The shares were disposed of at an average price of Rs 1,559.4 apiece. ICICI Prudential Mutual Fund (MF), SBI MF, and Societe Generale - ODI were the buyers of the shares.

Speaking of PVR, Research Analyst at Equitymaster Aditya Vora believes PVR is an all-or-nothing outcome, as the management tries to restructure its debt and expand operations. He believes it is a daredevil stock for 2023.
 

Lupin gets USFDA approval

India pharma company, Lupin on Monday said its alliance partner Caplin Steriles, has received United States Food and Drug Administration (USFDA) approval for its abbreviated new drug application Thiamine Hydrochloride injection USP, 200 mg/2 mL (100 mg/mL) multiple-dose vials.

According to IQVIA data for the 12-month period ending December 2022 Thiamine Hydrochloride injection USP had an annual sale of approximately US $ 36 m (about Rs 2,975.2 m) in the US (IQVIA MAT).

Thiamine Hydrochloride injection is used for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety.

Founded in 1968, Lupin is a fully vertically integrated company with the capability in manufacturing and market generic pharmaceuticals. The company has 15 manufacturing sites and 7 research centers.

Last week, Lupin Digital Health unveiled the results of digital therapeutics study with ACS Patients. During the same week, USFDA completed an inspection of Lupin's Bioresearch center in Pune with no observations.

Speaking of USFDA approvals, Biocon share price is under pressure after USFDA issued a complete response letter (CRL) for its wholly-owned subsidiary, Biocon Biologics.

More By This Author:

Sensex Today Falls 360 Points; Nifty Ends Below 17,000
Sensex Today Slumps 700 Points Tracking Weak Global Cues
Sensex Today Ends 355 Points Higher; Banking & IT Stocks Witness Buying